Development of a Zebrafish Larval Infection Model Using Microgavage
JoVE Encyclopedia of Experiments
Microbiology
0 views • 2:26 min • March 31st, 2026
Take an anesthetized zebrafish larva in the groove of an agarose mold. Its head is positioned upward at an angle for intestinal access during injection.
Cover it with low-melting agarose, then allow the agarose to solidify and immobilize the larva.
Take a microinjection needle containing pathogenic bacteria suspended in a tracer dye solution.
Under a stereomicroscope, position the needle at an angle and guide the needle through the agarose into the larval mouth.
Advance it through the food pipe into the intestine.
Inject the bacteria into the intestinal lumen and confirm delivery using the tracer dye. This non-invasive method, called microgavage, mimics the natural infection route.
Withdraw the needle. Cut the agarose and transfer the larva into fresh medium.
The bacteria replicate and release toxins that damage the intestinal epithelium, promoting bacterial invasion and colonization in deeper tissues.
The zebrafish infection model is ready for analysis.
In a 1.5% agarose plate with grooves, place a drop of 0.8% low-melting agarose onto the zebrafish larvae to cover.
Gently adjust the larvae with heads facing upright at 45-degree angles in the groove and tails against the wall of the groove. Gently operate the needle through the agarose, then into the mouth of zebrafish larvae, through the esophagus. Once the tip of the needle is inside the anterior intestinal bulb, press the injection pedal to release 0.5 to 1 nanoliters of bacteria culture.
Fill the lumen of the intestine. Do not let it overflow from the esophagus or cloaca. Gently withdraw the needle from the mouth of the zebrafish. Following gavage, rescue the infected zebrafish larvae from the agarose with a flexible microloader tip by first cutting the agarose away, then by lifting the larvae.
Overview
This protocol demonstrates the development of a zebrafish larval infection model using microgavage, allowing for the study of bacterial infections in a live organism. This method provides insights into bacterial invasion and colonization processes.
Key Study Components
Area of Science
- Microbiology
- Infection models
- Zebrafish research
Background
- Zebrafish are valuable models for studying infectious diseases.
- Microgavage allows for targeted delivery of pathogens.
- This method mimics natural infection routes.
- Understanding bacterial behavior in vivo is crucial for developing treatments.
Purpose of Study
- To establish a reliable zebrafish infection model.
- To investigate bacterial colonization and invasion mechanisms.
- To facilitate research on host-pathogen interactions.
Methods Used
- Anesthetizing zebrafish larvae for immobilization.
- Using low-melting agarose to secure larvae during injection.
- Microinjecting bacteria into the intestinal lumen.
- Confirming injection success with tracer dye.
Main Results
- This protocol demonstrates the feasibility of using zebrafish for infection studies.
- Microgavage effectively delivers pathogens to the intestine.
- The model allows for observation of bacterial replication and toxin release.
- Infected larvae can be analyzed for tissue damage and bacterial behavior.
Conclusions
- The zebrafish larval model is a valuable tool for microbiological research.
- Microgavage provides a non-invasive method for studying infections.
- This approach can enhance understanding of host-pathogen dynamics.
Frequently Asked Questions
Executive Industry Relevance
Establishing physiologically relevant infection models is critical for de-risking antimicrobial target validation and mechanistic studies in early discovery. The zebrafish larval microgavage model enables direct observation of pathogen-host interactions in a live vertebrate system, supporting predictive confidence in lead identification. This approach bridges in vitro screening and mammalian studies by providing a scalable, disease-relevant platform for evaluating bacterial replication, toxin activity, and intestinal barrier function.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables functional validation of antimicrobial targets by assessing bacterial replication and toxin-mediated epithelial damage in a living host.
- Operational Value: Supports hypothesis-driven interrogation of virulence factors through controlled oral delivery of pathogens.
- Strategic Value: Reduces mechanistic ambiguity in target selection by modeling natural infection routes and downstream tissue invasion.
Screening & Assay Development
- Scientific Value: Generates quantitative readouts on bacterial load and toxin release using tracer-guided microinjection and fluorescence monitoring.
- Operational Value: Standardizes pathogen delivery via immobilized larvae in agarose molds, ensuring reproducible intestinal dosing across experimental batches.
- Strategic Value: Facilitates assay readiness for compound screening by establishing a consistent infection phenotype amenable to high-content imaging.
Translational & Preclinical Research
- Scientific Value: Provides disease-relevant systemic readouts by tracking bacterial translocation from intestine to deeper tissues post-infection.
- Operational Value: Enables longitudinal monitoring of infection progression in transparent larvae, supporting time-resolved efficacy testing.
- Strategic Value: Supports translational biomarker alignment by correlating epithelial damage metrics with bacterial colonization levels.
Pipeline & Workflow Integration
The model fits within the discovery continuum from target validation through lead optimization, offering a vertebrate-based infection readout that precedes mammalian preclinical studies.
- Discovery Biology: Supports mechanistic de-risking by visualizing spatiotemporal dynamics of bacterial replication and host response in real time.
- Screening: Delivers standardized, quantitative infection outputs via tracer dye confirmation and intestinal lumen filling, enabling dose-response assessments.
- Analytics: Generates measurable endpoints including bacterial replication kinetics, toxin-induced epithelial damage, and invasion depth for comparative condition analysis.
- Translational Research: Connects early discovery to preclinical continuity by modeling natural infection routes and systemic pathogen spread relevant to human C. difficile pathogenesis.
- Enterprise Reuse: Establishes a reusable platform for evaluating diverse antimicrobial candidates through standardized microgavage and agarose immobilization protocols.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence in target validation by reducing reliance on artificial infection models and capturing physiologically relevant host-pathogen dynamics.
- Operational Value: Ensures reproducibility through standardized larval immobilization, angled needle guidance, and controlled nanoliter-scale injections.
- Strategic Value: Improves go/no-go decision efficiency by providing early efficacy and toxicity signals in a whole-organism context.
- Portfolio Impact: Enables risk-adjusted prioritization of antimicrobial leads based on demonstrated activity in a disease-relevant vertebrate infection model.
Implementation Considerations
- Requires expertise in zebrafish larval handling, anesthesia, and agarose embedding techniques.
- Dependent on stereomicroscopy and microinjection instrumentation capable of sub-nanoliter volume delivery.
- Necessitates standardization of agarose concentration, larval orientation, and injection depth across users and sites.
- Involves adaptation considerations for different bacterial strains, tracer dyes, and infection timepoints based on pathogen characteristics.
- Practical limitations include larval survival post-procedure and the need for immediate transfer to recovery medium to maintain model integrity.
Biopharma FAQs
Probiotic Studies in Neonatal Mice Using Gavage
Related Videos
0 Views
Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
Related Videos
0 Views
Infection of Zebrafish Larvae with Aspergillus Spores for Analysis of Host-Pathogen Interactions
Related Videos
0 Views
Infection of Zebrafish Embryos with Intracellular Bacterial Pathogens
Related Videos
0 Views
Non-invasive Imaging of Disseminated Candidiasis in Zebrafish Larvae
Related Videos
0 Views
Microgavage of Zebrafish Larvae
Related Videos
0 Views
Gavaging Adult Zebrafish
Related Videos
0 Views
Modeling Mucosal Candidiasis in Larval Zebrafish by Swimbladder Injection
Related Videos
0 Views
Non-invasive Imaging of the Innate Immune Response in a Zebrafish Larval Model of Streptococcus iniae Infection
Related Videos
0 Views
Deciphering and Imaging Pathogenesis and Cording of Mycobacterium abscessus in Zebrafish Embryos
Related Videos
0 Views
Last updated: 22 August 2026